The healthcare analytical testing services market is expected to reach USD 5.97 Billion by 2023 from USD 3.09 Billion in 2017, at a CAGR of 11.7% According to a new market research report "Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioana ...

28.11.2019

Key Growth Opportunities of Healthcare Analytical Testing Services in Healthcare Industry

The healthcare analytical testing services market is expected to reach USD 5.97 Billion by 2023 from USD 3.09 Billion in 2017, at a CAGR of 11.7% According to a new market research report "Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, & Microbial Testing), End User (Pharmaceutical, Medical Device Companies, CRO) - Global Forecast to 2023", published by MarketsandMarkets

The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the Healthcare Analytical Testing Services Market.

Get Crucial Insights:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=108923833

"By type, the bioanalytical testing segment accounted for the largest share of the Healthcare Analytical Testing Services Market in 2017."

On the basis of type, the bioanalytical testing segment accounted for the largest share of the global Healthcare Analytical Testing Services Market. The large share of this segment is due to increasing number of drugs in the biopharmaceutical pipeline and the growing biopharmaceutical industry.

Browse and in-depth TOC on "Healthcare Analytical Testing Services Market"

286
36 - Figures
296 - Pages

"By end user, the pharmaceutical and biopharmaceutical companies segment held the largest market share of the Healthcare Analytical Testing Services Market in 2017."

Based on end user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the Healthcare Analytical Testing Services Market. The large share of this segment can be attributed to increasing outsourcing of analytical testing services by pharmaceutical and biopharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time required to validate the process and product.



"North America dominated the market in 2017."

North America accounted for the largest share of the Healthcare Analytical Testing Services Market in 2017, followed by Europe and Asia Pacific. The presence of a well-established pharmaceutical industry in the region, coupled with the high R&D expenditure, growth in the biosimilars and generics markets, increasing number of analytical testing service providers, and rising outsourcing of analytical testing by biopharmaceutical companies are the major factors responsible for the large share of North America in the global Healthcare Analytical Testing Services Market.

Please share your specific interest to serve you better | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=108923833

The prominent players in the global Healthcare Analytical Testing Services Market are Eurofins Scientific (Luxembourg), Wuxi PharmaTech (China), and Charles River Laboratories (US) held the major share of the Healthcare Analytical Testing Services Market and will continue to dominate the market between 2018 and 2023. Other major players operating in this market are Almac Group (UK), Exova Group (UK), PPD (US), Source BioScience (UK), Anabiotec (Belgium), Intertek Group (UK), and BioReliance (US).





Firma: MnM

Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt: Northbrook
Telefon: 18886006441


Diese PresseMitteilung kommt von businesspress24.com
https://www.businesspress24.com

Die URL für diese PresseMitteilung ist:
https://www.businesspress24.com/pressrelease1554310.html


Die PresseMitteilung stellt eine Meinungsäußerung des Erfassers dar. Der Erfasser hat versichert, dass die eingestellte PresseMitteilung der Wahrheit entspricht, dass sie frei von Rechten Dritter ist und zur Veröffentlichung bereitsteht. businesspress24.com macht sich die Inhalte der PresseMitteilungen nicht zu eigen. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht businesspress24.com